Home EEG monitors aim to Fine-Tune treatment for severe epilepsy
NCT ID NCT07225231
Summary
This study is testing whether a home monitoring system can help doctors better adjust a seizure medication called fenfluramine for people with Dravet syndrome or Lennox-Gastaut syndrome. About 20 participants will wear small, portable devices at home for a few days at a time to record brain activity and other vital signs. The goal is to see if this extra information gives doctors more confidence in their treatment decisions compared to standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRAVET SYNDROME (DS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.